Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05831449
PHASE3

CPL-01 in the Management of Postoperative Pain After Bunionectomy

Sponsor: Cali Pharmaceuticals LLC

View on ClinicalTrials.gov

Summary

Subjects receive study drug during bunionectomy and are followed for pain and opioid use, with the hypothesis that those who receive CPL-01 will have less pain and less opioid use than either control arm.

Official title: A Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Efficacy and Safety of CPL-01 in the Management of Postoperative Pain After Unilateral Distal First Metatarsal Bunionectomy With Osteotomy

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

616

Start Date

2023-05-22

Completion Date

2025-10-06

Last Updated

2026-04-30

Healthy Volunteers

No

Interventions

DRUG

Local anesthetic injection of CPL-01

Local anesthetic injection (CPL-01)

DRUG

Naropin, 0.5% Injectable Solution

Local anesthetic injection (positive control \[Naropin\])

DRUG

Placebo

Local anesthetic injection (negative control \[saline placebo\])

DRUG

Morphine rescue medication

Rescue opioid (IV morphine) allowed if requested

DRUG

Acetaminophen rescue medication

Rescue non-opioid (oral acetaminophen) allowed if requested

DRUG

Oxycodone rescue medication

Rescue opioid (PO oxycodone) allowed if requested

PROCEDURE

Bunionectomy

Operative bunion repair

Locations (1)

Todd Bertoch

Salt Lake City, Utah, United States